Literature DB >> 30524565

Impact of low-dose prednisolone on refractory pitting edema manifesting remitting seronegative symmetrical synovitis with pitting edema syndrome.

Yuhei Nojima1, Madoka Ihara1, Hidenori Adachi1, Tetsuya Kurimoto1, Shinsuke Nanto1.   

Abstract

We encountered an elderly male patient who after cardiac surgery for mitral stenosis had refractory pitting edema in both legs involving painful leg joints after a 1-month history of waxing and waning arthralgia. His family doctor had prescribed a combination of diuretics, 40 mg furosemide and 25 mg spironolactone; however, pitting edema in his lower legs persisted. He was diagnosed with worsening of congestive heart failure because of a previous cardiac surgery and was transferred to our hospital. On admission, we closely observed the patient's condition and noticed that his body temperature increased to 38.0 °C every evening. Furthermore, his ankle joints felt feverish and were swollen. Therefore, we suspected polyarthritis as an etiology, although we initially suspected rheumatoid arthritis (RA). Antibody testing did not support RA diagnosis; therefore we concluded the association of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome with his condition. After daily treatment with 15 mg prednisolone, the refractory edema symptom dramatically improved. The concept of RS3PE syndrome could explain such as an impressive clinical course. <Learning objective: Physicians encounter patients with pitting edema of unknown etiology in daily clinical practice. In particular, cardiologists usually tend to prescribe diuretics for patients with pitting edema in their legs. Cardiologists should consider RS3PE syndrome as a differential diagnosis, for patients with localized pitting edema in their extremities. This report cautions regarding arbitrarily prescribing diuretics for localized pitting edema.>.

Entities:  

Keywords:  Localized pitting edema; Low-dose prednisolone; Remitting seronegative symmetrical synovitis with pitting edema

Year:  2016        PMID: 30524565      PMCID: PMC6262095          DOI: 10.1016/j.jccase.2016.06.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  RS3PE syndrome. The relation with HLA B7.

Authors:  C Pease; B Bhakta
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Remitting seronegative symmetrical synovitis with pitting edema syndrome: followup for neoplasia.

Authors:  Pieranna Fietta; Paolo Manganelli
Journal:  J Rheumatol       Date:  2006-11       Impact factor: 4.666

Review 3.  Remitting seronegative symmetrical synovitis with pitting edema associated with parvovirus B19 infection: two new cases and review of the comorbidities.

Authors:  Francesco Drago; Giulia Ciccarese; Arianna F Agnoletti; Ludovica Cogorno; Alessandro Muda; Emanuele Cozzani; Aurora Parodi
Journal:  Int J Dermatol       Date:  2015-07-03       Impact factor: 2.736

4.  Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study.

Authors:  F Cantini; C Salvarani; I Olivieri; L Barozzi; L Macchioni; L Niccoli; A Padula; P Pavlica; L Boiardi
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

5.  RS3PE syndrome presenting as vascular endothelial growth factor associated disorder.

Authors:  K Arima; T Origuchi; M Tamai; N Iwanaga; Y Izumi; M Huang; F Tanaka; M Kamachi; K Aratake; H Nakamura; H Ida; M Uetani; A Kawakami; K Eguchi
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

6.  Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica.

Authors:  Makiko Kimura; Yasuharu Tokuda; Hideto Oshiawa; Kazuki Yoshida; Masako Utsunomiya; Tatsuo Kobayashi; Gautam A Deshpande; Kazuo Matsui; Mitsumasa Kishimoto
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

7.  Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome.

Authors:  D J McCarty; J D O'Duffy; L Pearson; J B Hunter
Journal:  JAMA       Date:  1985-11-15       Impact factor: 56.272

8.  Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.

Authors:  Eiichi Ito; Hiroshi Okamoto; Atsuko Mochizuki; Kuniko Ohara; Maiko Kato; Yutaka Terashima; Eiichi Tanaka; Kae Takagi; Shinichiro Uchiyama; Makoto Iwata
Journal:  Intern Med       Date:  2007-07-17       Impact factor: 1.271

9.  Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities.

Authors:  Masayuki Matsuda; Kumi Sakurai; Tomohisa Fushimi; Kanji Yamamoto; Shiho Rokuhara; Naritoshi Hosaka; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2004-02-11       Impact factor: 2.980

10.  Association of Remitting Seronegative Symmetrical Synovitis with Pitting Edema, Polymyalgia Rheumatica, and Adenocarcinoma of the Prostate.

Authors:  Amir Emamifar; Soeren Hess; Rannveig Gildberg-Mortensen; Inger Marie Jensen Hansen
Journal:  Am J Case Rep       Date:  2016-02-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.